(R)-(+)-Dropropizine

Selective and validated kinetic spectrophotometric method for the determination of irbesartan in pure and pharmaceutical formulations
S. Ashoura,∗, R. Bayram
Annales Pharmaceutiques Françaises Volume 77, Issue 2, March 2019, Pages 101-111
 
Development and Validation of a Stability-Indicating LC-Method for the Simultaneous Estimation of Levodropropizine, Chloropheniramine, Methylparaben, Propylparaben, and Levodropropizine Impurities
Palakurthi Ashok Kumar, Thummala Veera Raghava Raju,1 Dongala Thirupathi,1 Ravindra Kumar,1 and Jaya Shree
Sci Pharm. 2013 Jan-Mar; 81(1): 139–150.

(R)-(+)-Dropropizine is chemically (R)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol. (R)-(+)-Dropropizine is supplied with detailed characterization data compliant with regulatory guideline. (R)-(+)-Dropropizine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dropropizine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.